How different cancer cells respond to drug-delivering nanoparticles
The findings of a large-scale screen could help researchers design nanoparticles that target specific types of cancer.
When cells’ tiny differences have far-reaching implications
Alex Shalek’s technologies for single-cell RNA profiling can help dissect the cellular bases of complex diseases around the globe.
Microparticles could be used to deliver “self-boosting” vaccines
With particles that release their payloads at different times, one injection could provide multiple vaccine doses.
Tissue model reveals key players in liver regeneration
By tracing the steps of liver regrowth, MIT engineers hope to harness the liver’s regenerative abilities to help treat chronic disease.
Robert Langer wins BBVA Foundation Frontiers of Knowledge Award
Institute Professor honored for groundbreaking work in nucleic acid delivery and nanoparticles.
MIT-Northpond Program created to advance innovation in engineering and life sciences
The five-year collaboration aims to accelerate the translation of breakthrough engineering and biology for human health.
Nanoparticle sensor can distinguish between viral and bacterial pneumonia
Using this diagnostic, doctors could avoid prescribing antibiotics in cases where they won’t be effective.
Engineers develop nanoparticles that cross the blood-brain barrier
Tested using a new brain tissue model, the particles may be able to deliver chemotherapy drugs for glioblastoma.
3 Questions: Daniel Anderson on the progress of mRNA vaccines
Following the successful development of vaccines against Covid-19, scientists hope to deploy mRNA-based therapies to combat many other diseases.
Three from MIT elected to the National Academy of Sciences for 2022
Faculty members Angela Belcher, Pablo Jarillo-Herrero, and Ronitt Rubinfeld elected by peers for outstanding contributions to research.
MIT Research Slam showcases postdoc and PhD communication skills
The 2nd Annual Research Slam featured three-minute talks on cutting-edge research from across MIT in an engaging public showcase and competition.
New tool reveals how immune cells find their targets
MIT biological engineers have developed a simple way to identify B or T cells that interact with viral or bacterial proteins.
Advocating for vaccine equity
Postdoc Digbijay Mahat became a cancer researcher to improve health care in Nepal, but the Covid-19 pandemic exposed additional resource disparities.
A possible new Covid-19 vaccine could be accessible for more of the world
The protein subunit vaccine, which can be manufactured using engineered yeast, has shown promise in preclinical studies.
Mentorship and medicine
MIT senior Daniel Zhang aims to provide hope for young patients and support to young students.